Pharmacology
All Targets
7-TM Receptors
Ion Channels
Nuclear Receptors
Enzyme-Linked Receptors
Transporters
Enzymes
Other Pharmacology
Cellular Processes
Angiogenesis
Apoptosis
Cell Cycle
Cell Metabolism
Cytoskeleton & Motor Proteins
ECM & Adhesion Molecules
Signal Transduction
Stem Cells
Product Type
All Products
New Products
Small Molecules
Peptides
Antibodies
Jena Bioscience
Controlled Substances
Toxins
Caged Compounds
Fluorescent Probes
Screening Libraries
Ligand Sets
Other Product Types
Research Area
Cancer
Cardiovascular Disease
Endocrinology
Immunology
Metabolic Disease
Neurological Disease
Pain & Inflammation
Respiratory Disease
Ko 143Cat No. 3241 |
Price and Availability |
|
Chemical Name: (3S,6S,12aS)-1,2,3,4,6,7,12,12a-Octahydro-9-methoxy-6-( 2-methylpropyl)-1,4-dioxopyrazino[1',2':1,6]pyrido[3,4- b]indole-3-propanoic acid 1,1-dimethylethyl ester |
|
Biological Activity
Potent and selective breast cancer resistance protein multidrug transporter (BCRP) inhibitor (EC90 = 26 nM). Displays > 200-fold selectivity over P-gp and MRP-1 transporters. Increases intracellular drug accumulation and reverses BCRP-mediated multidrug resistance.Technical Data
M.Wt:469.57
Formula:C26H36N3O5
Solubility:Soluble to 50 mM in DMSO and to 100 mM in ethanol
Purity: >99 %
Storage:Desiccate at -20°C
CAS No:[461054-93-3]
The technical data provided above is for guidance only.
For batch specific data refer to the Certificate of Analysis and MSDS.
Resources
Certificate of Analysis / MSDS
Certificate of Analysis: View current batch
For specific/earlier batch please select:
Material Safety Data Sheet: View current batch
For specific/earlier batch please select:
References
Loevezijn et al (2001) Inhibition of BCRP-mediated drug efflux by fumitremorgin-type indolyl diketopiperazines. Bioorg.Med.Chem.Letts. 11 29. Allen et al (2002) Potent and specific inhibition of breast cancer resistance protein multidrug transporter in vitro and in mouse intestine by a novel analogue of fumitremorgin C. Mol.Cancer Ther. 1 417. Allen et al (2003) Mouse breast cancer resistance protein (Bcrp1/Abcg2) mediates etoposide resistance and transport, but etoposide oral availability is limited primarily by P-glycoprotein. Cancer Res. 63 1339.If you know of a useful citation for this product please let us know.
View Related Products by Target
Keywords: Ko 143, Potent, selective, BCRP, inhibitors, MDR, Breast, Cancer, Resistance, Protein, Multidrug, Transporters, Ko143
Buy Now / Print Quote
Find multiple products by catalog number
New Products in this Area
Pyrimethamine
Potent inhibitor of multi-drug and toxin extrusion (MATE) transporters; also inhibits DHFR
Sign-up for new product e-alerts
2009-10 Catalog
Our range of over 3,000 life science reagents represents a unique collection of novel and exclusive research tools. Request a copy or view PDF today.




